RGD With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defect
Launched by MINIA UNIVERSITY · Apr 17, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new, less invasive technique for treating periodontal intrabony defects, which are deep pockets in the gums caused by gum disease. The goal is to improve healing and tissue regeneration in these areas by enhancing the stability and recruitment of cells needed for repair. Researchers believe that using this minimally invasive approach, which preserves more of the surrounding tissue, could lead to better outcomes for patients suffering from moderate to advanced gum disease.
To participate in this trial, you would need to be between 65 and 74 years old and diagnosed with moderate to advanced periodontitis. It's important that you do not have any serious health conditions and haven’t received any regenerative periodontal treatments in the last six months. If you join the study, you can expect to receive care related to your gum condition while helping researchers learn more about the effectiveness of this new treatment. Keep in mind that those who smoke, are pregnant, or have had certain medications recently may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • All patients included will have moderate to advanced periodontitis.
- • Patients included in this study will be free from any systemic diseases according to criteria of Modified Cornell Medical Index(10).
- • Patients who had not undergone any type of regenerative periodontal therapy six months prior to the initial examination.
- Exclusion Criteria:
- • • Patients with systemic diseases, smokers, pregnant (female).
- • Patients received antibiotics or non-steroidal anti-inflammatory drugs six months before the beginning of the study.
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported